Possible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infant

dc.authorid113476en_US
dc.authorid113274en_US
dc.authorid31161en_US
dc.authorid102525en_US
dc.contributor.authorElkıran, Özlem
dc.contributor.authorKarakurt, Cemşit
dc.contributor.authorKoçak, Gülemdar
dc.contributor.authorTabel, Yılmaz
dc.contributor.authorGüngör, Serdal
dc.date.accessioned2018-01-18T11:10:02Z
dc.date.available2018-01-18T11:10:02Z
dc.date.issued2015
dc.departmentİnönü Üniversitesien_US
dc.descriptionArch Med Sci 2015; 11, 1: 235–236en_US
dc.description.abstractFluconazole, an azole antifungal agent, inhibits the fungal cytochrome P450 enzyme. Although in vitro data show that fluconazole is not a potent inhibitor of mammalian P450 enzymes, hyperkalemia secondary to adrenal insufficiency associated with fluconazole has been described rarely [1–3]. However, life-threatening severe hyperkalemia related to administration of intravenous fluconazole without adrenal suppression has not been reported before.en_US
dc.identifier.citationÖ. Elkıran, C. Karakurt, G. Koçak, Y. Tabel, And S. Güngör, “Possible Association Between Fluconazole Administration And Acute Hyperkalemia İn A Critically İll Cyanotic İnfant ,” Arch Med Sci, Vol. 11, No. 1, Pp. 235–6, 2015.en_US
dc.identifier.endpage236en_US
dc.identifier.issue1en_US
dc.identifier.startpage235en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379377/pdf/AMS-11-24661.pdf
dc.identifier.urihttps://hdl.handle.net/11616/7998
dc.identifier.volume11en_US
dc.language.isoenen_US
dc.publisherArch Med Scien_US
dc.relation.ispartofArch Med Scien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.titlePossible association between fluconazole administration and acute hyperkalemia in a critically ill cyanotic infanten_US
dc.typeArticleen_US

Dosyalar

Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: